The Doctor Challenging Decades of Dementia Research
Most research has focused on wealthy countries and people of European ancestry. In Kenya and Nigeria, Chi Udeh-Momoh is testing what prevention looks like when African communities help shape the science.

Dementia research has largely focused on wealthy countries and people of European ancestry. In the United States alone, federal funding for Alzheimer’s and dementia research totals about $3.9 billion annually, according to the Alzheimer’s Association.
But in the African communities neuroscientist Chi Udeh-Momoh works with, families are confronting a disease that too often goes unrecognized—and prevention strategies that have rarely been tested in their settings.
When people ask why she doesn’t study HIV, poverty, or infectious disease instead, her answer is straightforward: if not me, then who?
Udeh-Momoh, an associate professor of epidemiology and prevention, and gerontology and geriatrics medicine at Wake Forest University School of Medicine in North Carolina and an academic faculty member at Aga Khan University in Kenya, is leading Africa-FINGERS, a program in Kenya and Nigeria designed to reduce dementia risk. Working with physicians, community health workers, researchers, and caregivers, she wants to understand how prevention can fit into the lives of people whose experiences have been missing from much of the research.
Finding those answers is becoming more urgent. A 2024 paper she co-authored cites projections that dementia cases could increase by more than 300 percent in parts of Africa by 2050, driven largely by the global population aging.
For Udeh-Momoh, the question is not simply how to bring existing care to more people. It is how to build the evidence for care that works for them. And for the African scientists and community organizers involved, it’s more than research. It’s an act of love.
Udeh-Momoh has always been fascinated by the brain. But the urgency she brings to her work is also deeply personal.
While completing her undergraduate studies at the University of Manchester, Udeh-Momoh lost her mother. Her father died about a year later. Neither parent had been diagnosed with dementia, she says, but both had health factors known to increase the risk of developing it.
Those losses helped shape the questions that would eventually drive her research: What happens when conditions that put people at risk of dementia go unrecognized or poorly managed? And how might addressing those risks earlier help protect brain health? Her work now centers on identifying those risks and building resilience before cognitive decline takes away a person’s independence.
“I don’t want to get dementia. It's the most horrible thing ever. I can’t imagine it,” she says. “I realize I can’t sit down and say I don’t want to get it, I need to do something about it.”
Dementia is not an inevitable part of aging, says Udeh-Momoh. It describes a syndrome that can affect memory, thinking, and the ability to carry out daily activities. Alzheimer’s disease is its most common cause, but other diseases and overlapping health problems can contribute to those symptoms. Understanding who develops them, and why, requires studying multiple populations.
Globally, about 16 percent of the world’s population has European ancestry. Yet a 2024 review found that 82 percent of genetic studies examining neurodegenerative diseases focused predominantly on people of European ancestry.

The gaps also shape when families get answers. People may live with symptoms for years before reaching care. Studies in the United States have found that Black adults are more likely to receive delayed dementia diagnoses. In Kenya, researchers have documented how limited awareness and stigma can keep families from understanding the symptoms or seeking help. A shortage of specialists, combined with research that rarely reflects African populations, can delay answers further.
(What are the signs of dementia—and why is it so hard to diagnose?)
Researchers are exploring ways to recognize cognitive decline beyond specialist clinics, from early-detection guidance for health workers to experimental saliva tests and digital tools that analyze changes in speech. Some could eventually make screening more accessible in rural and underserved communities. But whether they work equally well across populations depends on who is included in the research.
Expanding access is only part of the challenge. Researchers also need to know whether the biological markers used to identify Alzheimer’s translate across populations. Amyloid and tau are hallmark proteins associated with Alzheimer’s disease, but what matters is how they change and accumulate abnormally in the brain. These changes can begin years before symptoms appear and can now be detected through brain scans, spinal fluid tests, and increasingly blood tests. Yet many thresholds used to interpret these biomarkers were developed largely in people of European ancestry, says Udeh-Momoh, leaving questions about how broadly they apply.
One 2021 analysis of screening data from a larger Alzheimer’s study found lower amyloid levels on brain scans among cognitively normal Black participants than among white participants. The researchers cautioned, however, that the study’s eligibility requirements may have influenced who was included. For Udeh-Momoh, the study points to a larger question: What happens when the future of brain health is built on data from only a fraction of the world’s population—and what changes when the research finally reflects everyone else?
Udeh-Momoh’s research is grounded in the idea that more than biology shapes brain health. During a decade of work with African communities, she kept seeing the same troubling pattern: people were living with dementia symptoms for years before reaching care. Many also had unrecognized or poorly managed high blood pressure, diabetes, and other cardiometabolic conditions that can increase dementia risk.
The problem extends beyond dementia. According to the International Diabetes Federation, nearly three-quarters of diabetes cases among adults in Africa have not been diagnosed. The World Health Organization estimates that more than half of adults with hypertension in the region did not know they had it in 2019. Both conditions can increase the risk of cognitive decline. “So, they’re living with this for a long time, they’re not managing it, and of course, it’s driving dementia,” Udeh-Momoh says.
For her, that pattern presents an opportunity to identify and address those risks before families are struggling with advanced symptoms.
That is the goal of Africa-FINGERS, a research initiative Udeh-Momoh launched in 2017. Its current five-year prevention program, launched in December 2024 and co-led with Finnish neuroscientist and geriatrician Miia Kivipelto, tests whether evidence-based dementia prevention strategies can be adapted to the social, cultural, and health realities of African communities. Africa-FINGERS is among Africa’s first large-scale dementia-prevention efforts. It operates across six sites in Kenya and Nigeria, with expansion planned for the Democratic Republic of the Congo and Cameroon.
The need is urgent. Kenya has fewer than 20 trained neurologists for a population of nearly 58 million; Nigeria has fewer than 100 for more than 230 million people.
(The reason dementia rates are rising is surprisingly simple.)
Africa-FINGERS has completed its first phase, during which researchers worked with community members to adapt the intervention across six areas: nutrition, physical activity, cardiometabolic health, cognitive and mental enrichment, social engagement, and stress management. It is now in its second phase, a 24-month randomized controlled trial.
Participants work with nutritionists, dietitians, clinicians, physiotherapists, and other experts. But this isn’t simply a conventional exercise-and-diet program transplanted into a new setting.
Music and dance sessions ask participants to respond to changing rhythms, coordinate different parts of the body, maintain their balance, and follow the group at the same time. The movements combine aerobic exercise, strength, balance, and cognitive stimulation, and they have been adapted to reflect cultural and religious considerations raised by community members.
The nutrition component takes a similarly practical approach. Dietitians draw on MIND diet principles but translate them into affordable, culturally familiar foods. Instead of handing participants an idealized menu, they work with what is available in a person’s home and identify changes that the household can realistically sustain. Family members may also participate because eating and exercise habits rarely belong to one person alone.
“What we’re building is not just a prevention strategy,” Udeh-Momoh says. “We want it to be sustainable even after the course of the intervention program. We want people to be able to adopt those health practices.”
The trial is ongoing, so researchers do not yet know whether Africa-FINGERS will improve participants’ cognitive health. But there is reason to test the approach. A 2024 Lancet Commission estimated that addressing 14 modifiable risk factors across the life course could potentially prevent or delay about 45 percent of dementia cases worldwide.
If the intervention proves effective, the program’s next phase will study its affordability, cost-effectiveness, and potential to expand through public and private health services. Researchers are already laying the groundwork. In Kenya, the Ministry of Health participated in the program’s 2024 launch, and the Africa-FINGERS team has contributed to discussions about a national dementia plan. In Nigeria, federal health officials, researchers, civil society groups, and the media have begun similar discussions about dementia prevention and a national strategy.
In the final phase, the team will share its findings with policymakers, health providers, nonprofits, and community organizations that could help put them into practice.

That work looks ahead to how dementia prevention might reach more adults. But Udeh-Momoh’s research also looks further back, at how childhood conditions, and even factors before birth, may shape brain health decades later.
“Early life factors matter a great deal, even maternal factors. What your mother did when she was pregnant can increase your risk for dementia,” Udeh-Momoh says. “We need people to understand that.”
Pointing to preliminary work from Brain Resilience Kenya, she says that poverty and limited educational opportunities may be linked to poorer cognitive health later in life. The findings don’t establish that childhood poverty causes dementia. But they show how the conditions that shape brain health—from nutrition and education to economic security and access to care—can accumulate over a lifetime.
“Our aim is ultimately to move dementia prevention upstream,” Udeh-Momoh says.
But making prevention work also means understanding what families face before they ever meet a researcher. Jackline Thairu knows that experience intimately.
In early 2017, she noticed subtle changes in her father. He repeated the same stories more and more often—first days apart, then hours, then minutes. Shortly afterward, he began getting lost on the two-hour trip to his office in Nairobi, a journey he made only two or three times a month. From then on, Thairu’s mother accompanied him whenever he needed to go, until his memory declined to the point where he could no longer work. Two years later, at 59, he was diagnosed with dementia. “I went into denial,” Thairu says. “I could still talk with him. I could still have a conversation even if he would forget. He would still recognize me. So, I just put it somewhere in the back of my mind.”
But her father’s condition continued to decline. Two years ago, he stopped recognizing her. These days, Thairu’s dad is almost entirely dependent on others. He can still chew and eat, but he can’t speak or move on his own. Most of the time, he sleeps. Occasionally, he smiles when he sees Thairu’s mother.
“It’s been hard. It’s been the most heartbreaking thing I’ve had to go through in my adult life,” Thairu says. “My dad was—he is—I keep saying ‘he was’ because it’s like two different people now. He was such a jovial, generous, happy, loving father and seeing him so helpless is crushing.”
Thairu travels two and a half hours from Nairobi, where she lives, to see her parents in the village of Muthuaini. Her mother tells her many people in the community are likely living with dementia without realizing it. Sudden outbursts, confusion, and changes in behavior are often misunderstood as something else entirely. “You’ll be told it’s witchcraft. My mom went through this; she was accused of having bewitched my dad,” she says. “Instead of taking care of the people, they become abandoned in the community. It’s quite sad.”
Thairu joined the Africa-FINGERS program as a community advisory board member, hoping to raise awareness about dementia in Kenya and encourage communities to care for patients rather than fear or reject them.
To better understand negative beliefs about the disease, Udeh-Momoh has partnered with researchers like Edna Bosire, an assistant professor of medical anthropology and implementation science at the Brain and Mind Institute at Aga Khan University in Nairobi.
Bosire explains that cultural attitudes linking dementia symptoms to witchcraft are often rooted in limited awareness about the condition and how it manifests. In 2024, she co-authored a report that documented negative perceptions about, and even violence towards, dementia patients in the Kenyan coastal town of Kilifi. “The community ostracizes these populations,” she says, “isolates them, kills them and because the family wants to protect them, they lock them within the houses.”
Mental health has become a more visible subject in Kenya in recent years, Bosire says. But she rarely hears the same conversations about dementia or other brain health conditions. With greater public awareness, she hopes to educate community health promoters who serve as on-the-ground ambassadors.
(Living with dementia in southern Africa is a heartbreaking challenge.)
Bosire now leads community engagement for Africa-FINGERS in Kilifi and Nairobi. During the program’s first phase, her team spoke with community members, local leaders, and policymakers about the proposed intervention. Their feedback helped researchers adapt the food guidance, music, movement, and other activities before the trial began.
Her team is now recruiting 300 adults who are at increased risk of dementia or living with mild cognitive impairment. Researchers will test whether a culturally adapted combination of nutrition, exercise, cardiometabolic care, cognitive stimulation, social engagement, and stress management can support cognitive health in these communities.
“For the first time, we are going to provide Afrocentric findings, findings that truly reflect African settings,” Bosire says. “When looking at global statistics, everything is Eurocentric, but we want to put ourselves on the map and say, from Africa, these are our findings.”
Testing prevention in African communities is just one part of Udeh-Momoh’s effort to broaden dementia research. Another involves what scientists can learn from people after they die.
Postmortem brain analysis remains the gold standard for confirming and studying many neurodegenerative diseases because scientists can directly examine the biological changes occurring inside the brain. Those observations help researchers identify biomarkers, improve diagnostic tools, and better understand the pathways that drive diseases like Alzheimer’s.
But most brain donations in the U.S. come from non-Hispanic white individuals, leaving researchers with datasets that don’t reflect the world’s diversity. The imbalance extends to the infrastructure itself: The United States has dozens of brain banks, while organized brain banking in sub-Saharan Africa remains relatively new, with the first such repository established in Ibadan, Nigeria.
That leaves researchers with an incomplete picture of how neurological diseases develop across different ancestries, environments, and health histories.
At Wake Forest University, Udeh-Momoh is developing GIFT—Giving in Final Tribute—to increase brain-tissue donation from minority and underserved groups in the United States.
(Leaving your brain to science: don’t let myths dissuade you.)
Udeh-Momoh points to the Biobank for Aging Studies at Brazil’s University of São Paulo, where scientists have assembled one of the world’s largest collections of postmortem brains. Families are routinely approached about donation after death, helping researchers assemble a collection of more than 4,000 brains, including more than 2,200 that have undergone extensive neuropathological evaluation.
Scientists using the collection have examined connections between Alzheimer’s pathology and symptoms including agitation, anxiety, depression, appetite changes, and sleep disturbances. The collection’s value lies not in a simple comparison between white and nonwhite brains, but in giving researchers a wider range of lives and health histories to study.
For Thairu, the need for better research and better care is already painfully clear. Her father no longer recognizes her or her four brothers. To cope with the long uncertainty of his illness, she leans on two friends and a therapist.
“The thing with dementia, it’s like a slow grief,” she says. “So, you don’t get a timeline of when they will leave you.”
Udeh-Momoh knows that uncertainty, too. As she reflects on the people she hopes her research will help, she becomes emotional. “I’m crying from the frustration that Black health is still not prioritized. I’m crying because I have a little girl. I’m crying because I have loved ones. I’m crying because of all the people I see, time and time again, not getting an early diagnosis,” she says. “I’m crying because I don’t even know if that’s going to be me one day.”
She cannot know whether dementia will one day affect her own family. What she can do is work with scientists, health professionals, and families to give the communities she serves a seat at the table in research that will shape their care. The next breakthrough in dementia science may very well come from the communities it has spent the least time studying.